First Psoriatic Arthritis Program In The Country Comes To Philadelphia
Be Joint Smart educates public about devastating disease affecting 100,000 Pennsylvanians
PORTLAND, Ore., Oct. 1, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 100,000 Pennsylvanians and about 45,000 Philadelphia Metro residents. The two organizations present the first psoriatic-arthritis specific program in the Philadelphia area—Be Joint Smart—at the Crown Plaza Philadelphia Valley Forge on Saturday, Oct. 5. Learn more at www.bejointsmart.org.
Up to 30 percent of people with psoriasis—the most common autoimmune disease in the country—actually have psoriatic arthritis, an inflammatory disease that causes pain, swelling and stiffness of the joints and tendons. As many as 2 million Americans currently are diagnosed with psoriatic arthritis. Research from the National Psoriasis Foundation reveals nearly one in four people with psoriasis may have undiagnosed psoriatic arthritis. Early diagnosis and treatment of the disease is critical to prevent long-term joint damage and disability.
Through the Be Joint Smart live events, a leading rheumatologist and dermatologist will share how people with psoriatic arthritis can take control of their health, including:
- Ways to manage symptoms to help limit long-term joint damage
- Treatment options
- Tips for a healthy lifestyle
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts